News Daily News UK TAVI Registry Supports Use of Subclavian Access When Transfemoral Not Possible L.A. McKeown September 16, 2015
News Daily News Small Series Positive for Novel Transcatheter Mitral Valve in Functional MRPequeña Serie Positiva para una Nueva Válvula Mitral Transcatéter en el Manejo de la RM Funcional August 25, 2015
News Daily News Small Series Positive for Novel Transcatheter Mitral Valve in Functional MR August 25, 2015
News Daily News CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery L.A. McKeown August 19, 2015
News Daily News CHOICE a 1 Año: Sapien y CoreValve Ofrecen Resultados Clínicos Parecidos August 11, 2015
News Daily News Pulmonary Hypertension Type Predicts TAVR Outcome, Could Help Select Candidates Yael L. Maxwell August 05, 2015
News Daily News Subestudio del COURAGE: La PCI No Ofrece Beneficio Añadido sobre, Solo, el Tratamiento Médico Óptimo, ni en Hombres ni en Mujeres L.A. McKeown August 03, 2015
News Daily News Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR Todd Neale July 27, 2015
News Daily News ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves Yael L. Maxwell July 15, 2015
News Daily News Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years July 07, 2015
News Daily News CTOs Relatively Frequent in Patients Without Previously Known CAD Nicole Lou June 30, 2015
News Daily News FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients Yael L. Maxwell June 24, 2015
News Daily News Una Terapia Génica administrada por Catéter es Positiva en el Manejo de la Insuficiencia Cardíaca Avanzada June 23, 2015
News Daily News Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure June 23, 2015
News Industry News Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction June 22, 2015
News Industry News Edwards Receives FDA Approval For SAPIEN 3 Transcatheter Heart Valve June 17, 2015
News Industry News Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy June 16, 2015